![Daniel Chao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Daniel L.
Chao is the founder of Visgenx, Inc. Mr. Chao is currently Vice President & Head-Clinical Development at Surrozen, Inc. since 2025.
Postes actifs de Daniel Chao
| Sociétés | Poste | Début |
|---|---|---|
| SURROZEN, INC. | Corporate Officer/Principal | 01/07/2025 |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Develops therapeutics to protect against the loss of sight from retinal disorders | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Develops therapeutics to protect against the loss of sight from retinal disorders | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
